Vamsi Pharma
Contract development and manufacturing organisation (CDMO) and contract research organisation (CRO) focused on dry powder inhalation (DPI) products. Provides end-to-end services from API pre-formulation and particle engineering through analytical method development, clinical and commercial GMP manufacturing, device–formulation integration, technology transfer, and regulatory support. Operates a WHO-GMP certified facility in Telangana, India.
Industries
Nr. of Employees
small (1-50)
Products
DPI pipeline — combination inhalation formulations
Portfolio of dry powder inhaler formulations targeting respiratory therapies (dual and triple combination APIs) developed and in‑vitro characterised for regulatory and market readiness.
Bulk Capsules
Combination ready-to-fill inhalation blend containing Formoterol and Fluticasone for dry powder inhalers.
Levosalbutamol-Ipratropium Bulk Capsules
Bulk-filled DPI capsules containing Levosalbutamol-Ipratropium combination.
Salmeterol-Fluticasone Bulk Capsules
Combination ready-to-fill inhalation blend containing Salmeterol and Fluticasone for dry powder inhalers.
Tiotropium Bulk Capsules
Bulk-filled DPI capsules containing Tiotropium.
Finished Dose Formulations With Device
DPI finished dosage forms supplied as a ready-to-use combo pack with a single-use punch inhaler device and capsules in a bottle.
DPI pipeline — combination inhalation formulations
Portfolio of dry powder inhaler formulations targeting respiratory therapies (dual and triple combination APIs) developed and in‑vitro characterised for regulatory and market readiness.
Bulk Capsules
Combination ready-to-fill inhalation blend containing Formoterol and Fluticasone for dry powder inhalers.
Levosalbutamol-Ipratropium Bulk Capsules
Bulk-filled DPI capsules containing Levosalbutamol-Ipratropium combination.
Salmeterol-Fluticasone Bulk Capsules
Combination ready-to-fill inhalation blend containing Salmeterol and Fluticasone for dry powder inhalers.
Tiotropium Bulk Capsules
Bulk-filled DPI capsules containing Tiotropium.
Finished Dose Formulations With Device
DPI finished dosage forms supplied as a ready-to-use combo pack with a single-use punch inhaler device and capsules in a bottle.
Services
Premix manufacturing, bulk capsule production and finished DPI dosage forms with optional device integration for clinical and commercial supply.
End‑to‑end formulation and device development for generics and novel inhalation products including API pre‑formulation, particle engineering, DoE, aerosol optimization and stability studies.
Structured transfer master plans, validated analytical method packages, PPQ support, SOPs, training and post‑transfer optimisation to replicate product performance across sites.
Premix manufacturing, bulk capsule production and finished DPI dosage forms with optional device integration for clinical and commercial supply.
End‑to‑end formulation and device development for generics and novel inhalation products including API pre‑formulation, particle engineering, DoE, aerosol optimization and stability studies.
Structured transfer master plans, validated analytical method packages, PPQ support, SOPs, training and post‑transfer optimisation to replicate product performance across sites.
Expertise Areas
- Dry powder inhalation (DPI) development
- Particle engineering and aerosol science
- Device–formulation integration and human factors
- Analytical method development and validation for inhalation products
Key Technologies
- Jet milling (particle size reduction)
- Spray drying (particle engineering)
- Cascade impactor / NGI aerodynamic particle size analysis
- Precision powder metering and filling
News & Updates
From Concept to Commissioning: Why a Dry Powder Inhaler CDMO Accelerates Inhalation Drug Development
Blog describing a concept‑to‑commissioning model for DPI product development covering particle engineering, analytical readiness, manufacturing, technology transfer and regulatory preparedness.
Operates a WHO‑GMP certified facility for DPI and formulation manufacturing.
From Concept to Commissioning: Why a Dry Powder Inhaler CDMO Accelerates Inhalation Drug Development
Blog describing a concept‑to‑commissioning model for DPI product development covering particle engineering, analytical readiness, manufacturing, technology transfer and regulatory preparedness.
Operates a WHO‑GMP certified facility for DPI and formulation manufacturing.